Literature DB >> 3395303

The Sydney AIDS Project: development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men.

B Tindall1, D A Cooper, B Donovan, T Barnes, C R Philpot, J Gold, R Penny.   

Abstract

The Sydney AIDS Project is a prospective immunoepidemiological study of 996 homosexual/bisexual men enrolled between February 1984 and January 1985. By January 1987, 32 of 386 homosexual men who were seropositive at enrollment in the study had developed AIDS, yielding a crude progression rate of between 2.8% and 4.2% per annum. Of these subjects, 23 (72%) developed AIDS within 12 months of enrollment. In univariate analysis, the only lifestyle differences between seropositive subjects who progressed to AIDS and those that did not progress were less frequent oral sex activity and more use of marijuana in the three months prior to enrollment. In multivariate analysis, seropositive subjects who progressed to AIDS were more likely to have a lower percentage of CD4+ cells, a higher percentage of CD8+ cells and to have used marijuana in the three months prior to enrollment than the seropositive subjects who did not progress. No HIV seropositive subject who was asymptomatic and had normal T-cell subsets at enrollment had developed AIDS by January 1987. Persistent generalised lymphadenopathy was not associated with progression to AIDS. Although there are a number of lifestyle factors that may be associated with HIV infection, this study did not implicate most of these in the progression of HIV seropositive subjects to end-stage AIDS. We conclude that antecedent changes in T-cell subsets are associated with progression to AIDS and we emphasise the prognostic value of enumeration of T-cell subsets in HIV seropositive persons.

Entities:  

Mesh:

Year:  1988        PMID: 3395303     DOI: 10.1111/j.1445-5994.1988.tb02232.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  13 in total

1.  Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.

Authors:  N J Bodsworth; P Cunningham; J Kaldor; B Donovan
Journal:  Genitourin Med       Date:  1996-04

Review 2.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

3.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

Review 4.  Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.

Authors:  Xu Wang; Wen-Zhe Ho
Journal:  Life Sci       Date:  2010-11-04       Impact factor: 5.037

5.  Chronic Δ-9-tetrahydrocannabinol administration increases lymphocyte CXCR4 expression in rhesus macaques.

Authors:  Nicole J LeCapitaine; Ping Zhang; Peter Winsauer; Edith Walker; Curtis Vande Stouwe; Constance Porretta; Patricia E Molina
Journal:  J Neuroimmune Pharmacol       Date:  2011-04-12       Impact factor: 4.147

6.  Chronic Δ⁹-tetrahydrocannabinol administration may not attenuate simian immunodeficiency virus disease progression in female rhesus macaques.

Authors:  Angela M Amedee; Whitney A Nichols; Nicole J LeCapitaine; Curtis Vande Stouwe; Leslie L Birke; Nedra Lacour; Peter J Winsauer; Patricia E Molina
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12       Impact factor: 2.205

7.  Recruitment, Follow-Up and Characteristics of HIV Infected Adults who Use Illicit Drugs in Southern Africa.

Authors:  Marianna K Baum; Adriana Campa; J Bryan Page; Shenghan Lai; Lesedi Tsalaile; Sabrina Sales Martinez; Patricia Burns; O'Dale Williams; Yinghui Li; Erik van Widenfelt; Herman Bussmann; Moyo Sikhulele; Joseph Makhema; Myron Essex; Richard Marlink
Journal:  J Drug Abuse       Date:  2015-12-08

Review 8.  Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model.

Authors:  Patricia E Molina; Angela M Amedee; Peter Winsauer; Steve Nelson; Gregory Bagby; Liz Simon
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-21       Impact factor: 4.147

9.  Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis.

Authors:  M Bofill; G Janossy; C A Lee; D MacDonald-Burns; A N Phillips; C Sabin; A Timms; M A Johnson; P B Kernoff
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 10.  Cannabinoid exposure during pregnancy and its impact on immune function.

Authors:  Catherine Dong; Jingwen Chen; Amy Harrington; K Yaragudri Vinod; Muralidhar L Hegde; Venkatesh L Hegde
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.